Saudi Journal of Gastroenterology · 2018 · 127 citations · 44 references
Continued high rates of adult obesity and DM, in combination with aging populations, suggest that advanced liver disease and mortality attributable to NAFLD/NASH will increase across both countries. Reducing the growth of the NAFLD population, along with potential therapeutic options, will be needed to reduce liver disease burden.
44
Marie Ng, Tom Fleming, Margaret S. Robinson et al. · The Lancet · 2014 · 11.9K citations · Full text
Paul Angulo, Jason M. Hui, Giulio Marchesini et al. · Hepatology · 2007 · 3.1K citations · Full text